SV7 (Imf) GP LLP
- SEC CIK
- 0001889859
No open-market purchases or sales filed in the past year.
Current role at each company
- XLO Xilio Therapeutics, Inc.10% Owneras of Nov 3, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists SV7 (Imf) GP LLP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2021 (view filing)4:20 PM ET | Oct 26 | 8 days | SV7 Impact Medicine Fund LP and 1 other10% Owner | PPurchase | +312.5K | $16.00 | +$5.00M | +24.0%1.61M after | Amended |
| Nov 3, 2021 (view filing)4:20 PM ET | Oct 26 | 8 days | SV7 Impact Medicine Fund LP and 1 other10% Owner | PPurchase | +312.5K | $16.00 | +$5.00M | +24.0%1.61M after | Amended |